Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113061594A details a robust immobilized transaminase process for sitagliptin intermediates, offering superior stability and simplified solvent systems for cost-effective API manufacturing.
Patent CN110218758A reveals enzymatic lutein ester synthesis offering high purity and mild conditions for reliable pharmaceutical intermediate supply chain optimization.
Novel synthesis of (S,E)-1,9-diene-4,6-diyne-3-octadecyl alcohol offers high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Novel alkaline trihalogenation process for 17-formic acid steroids offers high yield, purity, and reduced toxicity for API manufacturing.
Patent CN106397117A details a novel enzymatic resolution process yielding high-purity chiral alcohols with significant supply chain and cost advantages for global buyers.
Explore CN1087337A technology for leukotriene inhibitors. We offer reliable pharmaceutical intermediates supplier services with optimized etherification and alkylation routes.
Patent CN110305071A details high-yield SC 69124 synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN118852303A details a novel aminolysis method for cytidine vinyl phosphate, offering high purity and cost reduction in nucleoside manufacturing for global supply chains.
Novel preparation method for Raltitrexed degradation impurity ensures high purity and supply stability for pharmaceutical quality research and regulatory compliance.
Novel patent CN103880801B offers efficient treprostinil intermediate synthesis reducing cost and enhancing supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of Ethyl (R)-4-Cyano-3-Hydroxybutyrate via epoxide intermediate. High purity >99%, scalable process for Atorvastatin manufacturing.
Patent CN1165815A reveals dual-action phenol compounds for atherosclerosis. Discover cost reduction in API manufacturing and high-purity production capabilities.
Patent CN1022920C reveals one-pot synthesis for high-purity heterocyclic intermediates, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN103588662A details a novel continuous-flow method for synthesizing Betamipron, offering enhanced purity and reduced toxicity for reliable pharmaceutical intermediate supply chains.
Patent CN103588662A details a continuous-flow microreactor method for synthesizing Betamipron, offering superior purity and cost reduction in API manufacturing compared to conventional batch processes.
Patent CN110885290A discloses a novel route for 3-fluoro-2-methyl-4-trifluoromethylaniline hydrochloride via Buchwald-Hartwig amination, ensuring high purity and scalable production for pharmaceutical intermediates.
Patent CN116283706B details a scalable synthesis method for Nirmatrelvir intermediates offering high purity and cost reduction for pharmaceutical supply chains.
Novel lactone-opening route for Tolterodine tartrate. Reduces steps, eliminates harsh reagents, ensures high purity for commercial scale-up.
Patent CN1428345A details a safer gastrodin synthesis route eliminating red phosphorus. Achieve cost reduction in API manufacturing with scalable, high-purity phenolic glycosides.
Patent CN116283706B reveals optimized synthesis for namatevir intermediates ensuring high purity and scalable production for global supply chains.